The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas

The oncogenic transcription factor Myc is required for the progression and maintenance of diverse tumors. This has led to the concept that Myc itself, Myc-activated gene products, or associated biological processes might constitute prime targets for cancer therapy. Here, we present an in vivo revers...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Andrea, Aleco, Gritti, Ilaria, Nicoli, Paola, Giorgio, Marco, Doni, Mirko, Conti, Annalisa, Bianchi, Valerio, Casoli, Lucia, Sabò, Arianna, Mironov, Alexandre, Beznoussenko, Galina V., Amati, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341918/
https://www.ncbi.nlm.nih.gov/pubmed/27635472
http://dx.doi.org/10.18632/oncotarget.11719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341918/
https://www.ncbi.nlm.nih.gov/pubmed/27635472
http://dx.doi.org/10.18632/oncotarget.11719

Ejemplares similares